Calidi Biotherapeutics to Showcase Innovative Systemic Virotherapy Data at AACR 2025
Calidi Biotherapeutics Inc. (NYSE American: CLDI), a clinical-stage biotechnology firm focused on developing advanced antitumor virotherapies, has announced that its research abstract titled “Development of...
